Analysis of T cell subsets in cancer patients treated with interferon
- 1 December 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 75 (6) , 966-972
- https://doi.org/10.1016/0002-9343(83)90876-8
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer PatientsAnnals of Internal Medicine, 1982
- Human leukocyte interferon produced by E. coli is biologically activeNature, 1980
- Effect of Interferon-α1 from E. coli on Some Cell FunctionsScience, 1980
- Leukocyte Interferon-Induced Tumor Regression in Human Metastatic Breast Cancer, Multiple Myeloma, and Malignant LymphomaAnnals of Internal Medicine, 1980
- Induction and kinetics of natural killer cells in humans following interferon therapyNature, 1979
- Controlled Clinical Trial of Prophylactic Human-Leukocyte Interferon in Renal TransplantationNew England Journal of Medicine, 1979
- Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicityNature, 1979
- Preliminary Observations on the Effect of Human Leukocyte Interferon in Non-Hodgkin's LymphomaNew England Journal of Medicine, 1978
- Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation.The Journal of Experimental Medicine, 1978
- Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active HepatitisNew England Journal of Medicine, 1976